Abbott announces FDA clearance of Cell-Dyn Ruby hematology instrument

By Elaine Rigoli

Tampa, Fla., July 19 - Abbott has received 510(k) clearance from the Food and Drug Administration for its automated, mid-volume hematology instrument, Cell-Dyn Ruby.

The company said this instrument offers enhanced cellular analysis and greater efficiency for laboratories performing complete blood counts, a test routinely ordered by doctors to assess a patient's overall health and to screen for a variety of disorders such as anemia and infection.

Cell-Dyn Ruby uses laser light to differentiate cellular components for detailed results in easy-to-view diagrams, the company said in a news release.

Abbott is a health care company located in Abbott Park, Ill.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.